• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种具有唾液酸化二岩藻糖基Lex活性的新型糖蛋白在慢性肝病活动性炎性病变中的肝细胞表达。

Hepatocellular expression of a novel glycoprotein with sialylated difucosyl Lex activity in the active inflammatory lesions of chronic liver disease.

作者信息

Okada Y, Shimoe T, Muguruma M, Usumoto R, Tsuji T, Jinno K, Moriwaki S, Shin S, Hakomori S

机构信息

Department of Internal Medicine, Okayama University Medical School, Japan.

出版信息

Am J Pathol. 1988 Feb;130(2):384-92.

PMID:3341453
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1880517/
Abstract

Hepatic expression of sialylated difucosyl Lex antigen (SDLex, NeuAc alpha 2-3Gal beta 1-4(Fuc alpha 1-3)GlcNAc beta 1-3Gal beta 1-4(Fuc alpha 1-3)GlcNAc beta 1-) was studied with monoclonal antibody FH6, which defines this structure. Hepatocytes in the severe form of chronic active hepatitis and liver cirrhosis strongly expressed SDLex. The antigen was only weakly and focally detected in chronic persistent hepatitis. The mild form of chronic active hepatitis showed intermediate expression. SDLex expressed along the liver cell membranes displayed a honeycomb pattern when extensively expressed in the severe form of chronic active hepatitis or in liver cirrhosis. Cytoplasmic expression was faint and focal. Preferential tissue distribution was at the periphery of the hepatic lobules where the distruction of the limiting plate was present. The antigen was also expressed in sinusoidal lining cells and polymorphonuclear cells but not in the biliary epithelia. Hepatocytes expressing SDLex did not express related carbohydrate antigens, ie, Type 2 chain N-acetyllactosamine, Lex, and sialylated Lea. On subcellular fractionation, the microsome fraction contained the majority of the antigen activity. SDS-PAGE and Western blot analysis revealed one major SDLex-active glycoprotein with an apparent molecular weight of 110 kilodaltons. This glycoprotein was different from SDLex-active glycoproteins found in the sera of cancer patients. No ganglioside showed FH6 reactivity. These results indicate that liver cells in active inflammatory lesion expressed a novel glycoprotein carrying SDLex antigen in honeycomblike membrane-associated pattern.

摘要

用定义该结构的单克隆抗体FH6研究了唾液酸化二岩藻糖基Lex抗原(SDLex,NeuAcα2-3Galβ1-4(Fucα1-3)GlcNAcβ1-3Galβ1-4(Fucα1-3)GlcNAcβ1-)的肝脏表达情况。在慢性活动性肝炎和肝硬化的严重形式中,肝细胞强烈表达SDLex。在慢性持续性肝炎中,仅微弱且局灶性地检测到该抗原。轻度慢性活动性肝炎表现为中等表达。在慢性活动性肝炎严重形式或肝硬化中广泛表达时,沿肝细胞膜表达的SDLex呈现蜂窝状模式。细胞质表达微弱且局灶性。优先的组织分布位于存在界板破坏的肝小叶周边。该抗原也在窦状隙衬里细胞和多形核细胞中表达,但不在胆管上皮中表达。表达SDLex的肝细胞不表达相关的碳水化合物抗原,即2型链N-乙酰乳糖胺、Lex和唾液酸化Lea。在亚细胞分级分离中,微粒体部分含有大部分抗原活性。SDS-PAGE和蛋白质印迹分析显示一种主要的具有SDLex活性的糖蛋白,其表观分子量为110千道尔顿。这种糖蛋白与癌症患者血清中发现的具有SDLex活性的糖蛋白不同。没有神经节苷脂显示出FH6反应性。这些结果表明,活动性炎性病变中的肝细胞以蜂窝状膜相关模式表达一种携带SDLex抗原的新型糖蛋白。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c259/1880517/718ab1952cfb/amjpathol00137-0178-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c259/1880517/e6c75aa066ca/amjpathol00137-0175-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c259/1880517/515bb4a4099c/amjpathol00137-0176-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c259/1880517/4a126e6ad1fe/amjpathol00137-0177-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c259/1880517/9423acdeb33d/amjpathol00137-0177-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c259/1880517/718ab1952cfb/amjpathol00137-0178-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c259/1880517/e6c75aa066ca/amjpathol00137-0175-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c259/1880517/515bb4a4099c/amjpathol00137-0176-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c259/1880517/4a126e6ad1fe/amjpathol00137-0177-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c259/1880517/9423acdeb33d/amjpathol00137-0177-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c259/1880517/718ab1952cfb/amjpathol00137-0178-a.jpg

相似文献

1
Hepatocellular expression of a novel glycoprotein with sialylated difucosyl Lex activity in the active inflammatory lesions of chronic liver disease.一种具有唾液酸化二岩藻糖基Lex活性的新型糖蛋白在慢性肝病活动性炎性病变中的肝细胞表达。
Am J Pathol. 1988 Feb;130(2):384-92.
2
Sialyl-dimeric Lewis-X antigen expressed on mucin-like glycoproteins in colorectal cancer metastases.唾液酸化二聚体Lewis-X抗原在结直肠癌转移灶的黏蛋白样糖蛋白上表达。
Lab Invest. 1990 Dec;63(6):780-91.
3
Gangliosides and sialoglycoproteins carrying a rare blood group antigen determinant, Cad, associated with human cancers as detected by specific monoclonal antibodies.通过特异性单克隆抗体检测发现,神经节苷脂和唾液酸糖蛋白携带一种罕见血型抗原决定簇Cad,与人类癌症相关。
Cancer Res. 1990 Sep 1;50(17):5497-503.
4
A carbohydrate epitope associated with human squamous lung cancer.一种与人类肺鳞状细胞癌相关的碳水化合物表位。
Cancer Res. 1988 Apr 15;48(8):2125-31.
5
Expression of sialylated Lewis(x) antigen in chronic and neoplastic liver diseases.唾液酸化路易斯(x)抗原在慢性肝病和肿瘤性肝病中的表达
Arch Pathol Lab Med. 1992 Jun;116(6):643-8.
6
Distribution of VIM-2 and SSEA-1 glycoconjugate epitopes among human leukocytes and leukemia cells.VIM-2和SSEA-1糖缀合物表位在人白细胞和白血病细胞中的分布。
Leuk Res. 1990;14(2):119-30. doi: 10.1016/0145-2126(90)90040-g.
7
Significant increase in the antibody to Gal alpha 1-3Gal structure in sera of patients with hepatocellular carcinoma after transcatheter arterial embolization.经导管动脉栓塞术后肝细胞癌患者血清中抗Galα1-3Gal结构抗体显著增加。
Cancer Res. 1989 Aug 15;49(16):4396-401.
8
In situ distribution of enolase isozymes in chronic liver disease.烯醇化酶同工酶在慢性肝病中的原位分布
Am J Gastroenterol. 1989 Jun;84(6):601-5.
9
Monosialogangliosides of human myelogenous leukemia HL60 cells and normal human leukocytes. 2. Characterization of E-selectin binding fractions, and structural requirements for physiological binding to E-selectin.人髓性白血病HL60细胞和正常人白细胞的单唾液酸神经节苷脂。2. E-选择素结合组分的特性,以及与E-选择素生理性结合的结构要求。
Biochemistry. 1996 Jan 23;35(3):770-8. doi: 10.1021/bi952461g.
10
The binding rate of sialic acid to serum alpha 1-acid glycoprotein in patients with chronic hepatic injury.慢性肝损伤患者中唾液酸与血清α1-酸性糖蛋白的结合率。
Gastroenterol Jpn. 1987 Aug;22(4):448-52. doi: 10.1007/BF02773812.

引用本文的文献

1
Inflammation-induced expression of sialyl Lewis X-containing glycan structures on alpha 1-acid glycoprotein (orosomucoid) in human sera.炎症诱导人血清中α1-酸性糖蛋白(血清类黏蛋白)上含唾液酸化路易斯X聚糖结构的表达。
J Exp Med. 1993 Mar 1;177(3):657-66. doi: 10.1084/jem.177.3.657.

本文引用的文献

1
A simple method for the isolation and purification of total lipides from animal tissues.一种从动物组织中分离和纯化总脂质的简单方法。
J Biol Chem. 1957 May;226(1):497-509.
2
Detection of gangliosides that bind cholera toxin: direct binding of 125I-labeled toxin to thin-layer chromatograms.结合霍乱毒素的神经节苷脂的检测:125I标记毒素与薄层层析图的直接结合
Anal Biochem. 1980 Dec;109(2):399-402. doi: 10.1016/0003-2697(80)90667-3.
3
A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II.
一种与胃肠道癌相关的单克隆抗体定义抗原是一种含有唾液酸化乳糖-N-岩藻五糖II的神经节苷脂。
J Biol Chem. 1982 Dec 10;257(23):14365-9.
4
Gangliosides: structure, isolation, and analysis.神经节苷脂:结构、分离与分析
Methods Enzymol. 1982;83:139-91. doi: 10.1016/0076-6879(82)83012-7.
5
Immunohistochemical analysis of HLA (A, B, C) antigens in liver disease using a monoclonal antibody.使用单克隆抗体对肝脏疾病中HLA(A、B、C)抗原进行免疫组织化学分析。
Gut. 1981 Dec;22(12):985-91. doi: 10.1136/gut.22.12.985.
6
Glycosphingolipids in cellular interaction, differentiation, and oncogenesis.细胞相互作用、分化及肿瘤发生过程中的糖鞘脂
Annu Rev Biochem. 1981;50:733-64. doi: 10.1146/annurev.bi.50.070181.003505.
7
Distribution of HLA class 1 antigens in normal human tissue and in mammary cancer.人类主要组织相容性复合体I类抗原在正常人体组织及乳腺癌组织中的分布
J Clin Pathol. 1981 Jul;34(7):779-84. doi: 10.1136/jcp.34.7.779.
8
Isolation and characterization of three major glycoproteins from thyroid plasma membranes.
J Biol Chem. 1980 Sep 25;255(18):8865-72.
9
Glycosphingolipids as tumor-associated and differentiation markers.糖鞘脂作为肿瘤相关标志物和分化标志物。
J Natl Cancer Inst. 1983 Aug;71(2):231-51.
10
Basement membrane production by hepatocytes in chronic liver disease.慢性肝病中肝细胞产生基底膜的情况。
Hepatology. 1984 Nov-Dec;4(6):1167-72. doi: 10.1002/hep.1840040612.